Nicolas Erard, Simon R.V. Knott, Gregory J. Hannon  Molecular Cell 

Slides:



Advertisements
Similar presentations
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Advertisements

Hyunghoon Cho, Bonnie Berger, Jian Peng  Cell Systems 
Volume 16, Issue 3, Pages (March 2008)
Molecular recordings by directed CRISPR spacer acquisition
Sequential Response to Multiple Developmental Network Circuits Encoded in an Intronic cis-Regulatory Module of Sea Urchin hox11/13b  Miao Cui, Erika Vielmas,
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Volume 19, Issue 4, Pages (August 2005)
Volume 38, Issue 4, Pages (May 2010)
Volume 3, Issue 1, Pages (July 2016)
Global Mapping of Human RNA-RNA Interactions
Volume 44, Issue 3, Pages (November 2011)
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets  Benjamin P. Lewis, Christopher B. Burge,
Volume 54, Issue 1, Pages (April 2014)
AGEseq: Analysis of Genome Editing by Sequencing
Molecular Therapy - Nucleic Acids
Lu Bai, Andrej Ondracka, Frederick R. Cross  Molecular Cell 
N6-Methyladenosines Modulate A-to-I RNA Editing
Gaelen T. Hess, Josh Tycko, David Yao, Michael C. Bassik 
A Computational Algorithm to Predict shRNA Potency
Volume 34, Issue 3, Pages (August 2015)
Volume 9, Issue 4, Pages (October 2017)
Alternative Splicing QTLs in European and African Populations
Anastasia Baryshnikova  Cell Systems 
Genome Engineering with CRISPR-Cas9 in the Mosquito Aedes aegypti
Target-Specific Precision of CRISPR-Mediated Genome Editing
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
RRNA Modifications in an Intersubunit Bridge of the Ribosome Strongly Affect Both Ribosome Biogenesis and Activity  Xue-hai Liang, Qing Liu, Maurille.
Volume 22, Issue 3, Pages e3 (September 2017)
Volume 48, Issue 5, Pages (December 2012)
Xiaoyu Chen, Jin Liu, Josephine M. Janssen, Manuel A.F.V. Gonçalves 
Volume 154, Issue 6, Pages (September 2013)
Antigenic Variation in the Lyme Spirochete: Insights into Recombinational Switching with a Suggested Role for Error-Prone Repair  Theodore B. Verhey,
Volume 63, Issue 4, Pages (August 2016)
Volume 56, Issue 5, Pages (December 2014)
Expression Noise and Acetylation Profiles Distinguish HDAC Functions
Srinivas Ramachandran, Kami Ahmad, Steven Henikoff  Molecular Cell 
Systematic mapping of functional enhancer-promoter connections with CRISPR interference by Charles P. Fulco, Mathias Munschauer, Rockwell Anyoha, Glen.
Volume 44, Issue 3, Pages (November 2011)
Human Promoters Are Intrinsically Directional
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 69, Issue 1, Pages e3 (January 2018)
Volume 63, Issue 6, Pages (September 2016)
Volume 11, Issue 6, Pages (May 2015)
Baekgyu Kim, Kyowon Jeong, V. Narry Kim  Molecular Cell 
Volume 25, Issue 1, Pages (January 2017)
Nathan Pirakitikulr, Andrew Kohlway, Brett D. Lindenbach, Anna M. Pyle 
Volume 21, Issue 9, Pages (November 2017)
Volume 29, Issue 5, Pages (May 2016)
Volume 66, Issue 4, Pages e4 (May 2017)
Volume 63, Issue 3, Pages (August 2016)
DNA Looping Facilitates Targeting of a Chromatin Remodeling Enzyme
Volume 67, Issue 6, Pages e9 (September 2017)
Volume 20, Issue 3, Pages (July 2017)
Robert E. Johnson, Roland Klassen, Louise Prakash, Satya Prakash 
Fiona T van den Berg, John J Rossi, Patrick Arbuthnot, Marc S Weinberg 
Molecular Therapy - Nucleic Acids
Volume 26, Issue 6, Pages (June 2018)
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
Shiqi Xie, Jialei Duan, Boxun Li, Pei Zhou, Gary C. Hon  Molecular Cell 
Volume 16, Issue 2, Pages (February 2015)
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
Volume 41, Issue 2, Pages (January 2011)
Hyunghoon Cho, Bonnie Berger, Jian Peng  Cell Systems 
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Volume 8, Issue 5, Pages e8 (May 2019)
CRISPR Immunological Memory Requires a Host Factor for Specificity
Systematic Study of Nucleosome-Displacing Factors in Budding Yeast
Volume 71, Issue 2, Pages e5 (July 2018)
Volume 17, Issue 5, Pages (October 2016)
Volume 150, Issue 1, Pages (July 2012)
Presentation transcript:

A CRISPR Resource for Individual, Combinatorial, or Multiplexed Gene Knockout  Nicolas Erard, Simon R.V. Knott, Gregory J. Hannon  Molecular Cell  Volume 67, Issue 2, Pages 348-354.e4 (July 2017) DOI: 10.1016/j.molcel.2017.06.030 Copyright © 2017 The Authors Terms and Conditions

Molecular Cell 2017 67, 348-354.e4DOI: (10.1016/j.molcel.2017.06.030) Copyright © 2017 The Authors Terms and Conditions

Figure 1 CRoatan, an Algorithm for Identifying Potent sgRNAs (A) The potency of sgRNAs analyzed in Doench et al. stratified by conservation score (calculated as described in Figure S1B, ρ = 0.32). An sgRNA percentile is the percentile rank of an sgRNA relative to all other effectors targeting the same gene. This plot, as all others in the figure, was generated with the MATLAB boxplot function using default parameters. The edges of the box are the 25th and 75th percentiles. The error bars extend to the values q3 + w(q3 − q1) and q1 − w(q3 − q1), where w is 1.5 and q1 and q3 are the 25th and 75th percentiles. (B) Efficacy percentiles of the sgRNAs analyzed in Doench et al. when stratified by the likelihood of frameshift mutations (FSM likelihood) at the corresponding target site (rank-sum p value = 0.0405 for tertile 3 versus tertile 1 and 2 sgRNAs). (C) Efficacy percentiles of the sgRNAs analyzed in Doench et al. when stratified by the consolidated CRoatan algorithm (ρ = 0.52). (D) Z-score-normalized depletion rates of EG-sgRNAs when stratified by CRoatan score (ρ = 0.21). Depletion rates were calculated as the average log ratio in screens carried out in A-375 and K-562 cells. (E) Depletion rates of NEG- and EG-targeting sgRNAs in screens corresponding to those described in (D). sgRNA libraries were designed using the GPP-WP, sgRNAScorer, and Edit-R algorithms (rank-sum p value = 0.0942 for GPP-WP, 0.0209 for sgRNAScorer, and 0.0233 for Edit-R). Molecular Cell 2017 67, 348-354.e4DOI: (10.1016/j.molcel.2017.06.030) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Simultaneous Targeting with Multiple sgRNAs Results in Predictable Genomic Scars (A) Schematic map of the lentiviral, dual-sgRNA expression vector with relevant features highlighted. hU6, human U6 promoter; cU6, chicken U6 promoter; hsgRNA, human U6-promoter-driven sgRNA; csgRNA, human U6-promoter-driven sgRNA; HTS, high-throughput sequencing adapters; SFFV, spleen focus-forming virus promoter. (B) sgRNA pairing algorithm used to design five targeting constructs for a gene. The top 20 sgRNAs for each gene are filtered to a set of 10 to reduce the probability of off-targeting effects. Pairs within these 10 are then scored using the set of heuristics defined in Figure S2. The resultant pairing matrix is then used as input for a maximum-weighted matching algorithm to define a final set of 5 sgRNA pairs. (C) Paired-end sequencing analysis of genomic scars left after dual-CRoatan NEG-targeting constructs have been infected into A-375 and K-562 cells. hsgRNA and csgRNA indels are where only one of the two targeted regions shows mutational burden in an HTS fragment. hsgRNA and csgRNA indel counts represent cases where both targets have indels, and fragment deletions are where the region between the two targets is deleted. (D) Analysis of the genomic scars described in (C) that correspond to fragment deletions between two sgRNA target sites. The top ten most frequent deletions are shown with their corresponding rate of occurrence, as measured by their average frequency in infected A-375 and K-562 cells. Scars that result from exact deletion of the double-strand-break-flanked fragment are annotated as DSB-DSB deletions. Scars where, in addition to the fragment deletion, other bases are inserted or deleted are annotated as non-DSB-DSB deletions. Molecular Cell 2017 67, 348-354.e4DOI: (10.1016/j.molcel.2017.06.030) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Dual-CRoatan Constructs Provide Superior CRISPR-Based Gene Targeting (A) Average depletion rates for each EG-sgRNA when it is paired with NEG-sgRNAs (gray) and when it is paired with sgRNAs targeting the same EG (brown). sgRNAs are grouped based on the gene target; rank-sum p value = 0.0006. (B) Depletion rates of NEG- and EG-targeting CRISPR constructs in negative-selection screens. Shown are the consolidated depletion rates for single-sgRNA constructs selected using pre-existing tools (GPP, sgRNAScorer, or Edit-R algorithms) as well as the rates for CRoatan single-sgRNA constructs and CRoatan dual-sgRNA constructs (dual-CRoatan, rank-sum p value = 2.5e-5 for existing algorithms and p value > 0.05 for single-CRoatan constructs). Depletion rates were calculated as the average log ratio in screens carried out in A-375 and K-562 cells. This plot was generated with the MATLAB boxplot function using default parameters. The edges of the box are the 25th and 75th percentiles. The error bars extend to the values q3 + w(q3 − q1) and q1 − w(q3 − q1), where w is 1.5 and q1 and q3 are the 25th and 75th percentiles. (C) Gene-level analysis of CRoatan and CRoatan dual-sgRNA construct depletion rates. Using the average depletion rate for each construct in A-375 and K-562 cells, gene “hits” were calculated using a series of stringencies (top 10%, 20%, 30%, 40%, and 50% most-depleted sgRNAs). For a gene to be called a hit at a given stringency, a minimum of two constructs need to be depleted beyond the stringency level. Molecular Cell 2017 67, 348-354.e4DOI: (10.1016/j.molcel.2017.06.030) Copyright © 2017 The Authors Terms and Conditions